Mymetics announces change of Directors and management
Epalinges, Switzerland, 27 November 2012
Mymetics Corporation, a pioneer in the development of vaccines that use the human mucosal system, the body’s first line of defense, to prevent transmission of infectious diseases, announced today the appointment of Ronald Kempers, currently CFO and COO, as President and CEO of Mymetics Corporation effective November 19, 2012. He
replaces Dr. Christopher S. Henney and Grant Pickering who had been respectively appointed on March 22, 2012 as director and Chairman of the Board of Directors and as a director and President and Chief Executive Officer to pursue new strategic directions, including the potential change of Mymetics' location from Switzerland to the United States.
|Media Name||Media Type||Description||Download|
|121127 - Mymetics Corporation - Press release - 27.11.2012||Download|